Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diagnosis and prognosis of abnormal cardiac scintigraphy uptake suggestive of cardiac amyloidosis using artificial intelligence: a retrospective, international, multicentre, cross-tracer development and validation study.
Spielvogel CP, Haberl D, Mascherbauer K, Ning J, Kluge K, Traub-Weidinger T, Davies RH, Pierce I, Patel K, Nakuz T, Göllner A, Amereller D, Starace M, Monaci A, Weber M, Li X, Haug AR, Calabretta R, Ma X, Zhao M, Mascherbauer J, Kammerlander A, Hengstenberg C, Menezes LJ, Sciagra R, Treibel TA, Hacker M, Nitsche C. Spielvogel CP, et al. Among authors: haug ar. Lancet Digit Health. 2024 Apr;6(4):e251-e260. doi: 10.1016/S2589-7500(23)00265-0. Lancet Digit Health. 2024. PMID: 38519153 Free article.
Multicenter PET image harmonization using generative adversarial networks.
Haberl D, Spielvogel CP, Jiang Z, Orlhac F, Iommi D, Carrió I, Buvat I, Haug AR, Papp L. Haberl D, et al. Among authors: haug ar. Eur J Nucl Med Mol Imaging. 2024 Jul;51(9):2532-2546. doi: 10.1007/s00259-024-06708-8. Epub 2024 May 2. Eur J Nucl Med Mol Imaging. 2024. PMID: 38696130 Free PMC article.
Deep learning for [18F]fluorodeoxyglucose-PET-CT classification in patients with lymphoma: a dual-centre retrospective analysis.
Häggström I, Leithner D, Alvén J, Campanella G, Abusamra M, Zhang H, Chhabra S, Beer L, Haug A, Salles G, Raderer M, Staber PB, Becker A, Hricak H, Fuchs TJ, Schöder H, Mayerhoefer ME. Häggström I, et al. Lancet Digit Health. 2024 Feb;6(2):e114-e125. doi: 10.1016/S2589-7500(23)00203-0. Epub 2023 Dec 21. Lancet Digit Health. 2024. PMID: 38135556 Free PMC article.
Metabolic tumor volume and sites of organ involvement predict outcome in NSCLC immune-checkpoint inhibitor therapy.
Kifjak D, Hochmair M, Sobotka D, Haug AR, Ambros R, Prayer F, Heidinger BH, Roehrich S, Milos RI, Wadsak W, Fuereder T, Krenbek D, Fazekas A, Meilinger M, Mayerhoefer ME, Langs G, Herold C, Prosch H, Beer L. Kifjak D, et al. Among authors: haug ar. Eur J Radiol. 2024 Jan;170:111198. doi: 10.1016/j.ejrad.2023.111198. Epub 2023 Nov 21. Eur J Radiol. 2024. PMID: 37992608 Free article.
Neoadjuvant immune-checkpoint inhibitors in lung cancer - a primer for radiologists.
Kifjak D, Hochmair MJ, Krenbek D, Milos RI, Heidinger BH, Prayer F, Röhrich S, Watzenboeck ML, Oberndorfer F, Klikovits T, Aigner C, Sinn K, Hoda MA, Hoetzenecker K, Haug AR, Prosch H, Beer L. Kifjak D, et al. Among authors: haug ar. Eur J Radiol. 2023 Apr;161:110732. doi: 10.1016/j.ejrad.2023.110732. Epub 2023 Feb 8. Eur J Radiol. 2023. PMID: 36804313 Free article. Review.
A phase I/II study of the safety and efficacy of [177Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumours.
Wild D, Grønbæk H, Navalkissoor S, Haug A, Nicolas GP, Pais B, Ansquer C, Beauregard JM, McEwan A, Lassmann M, Pennestri D, Volteau M, Lenzo NP, Hicks RJ. Wild D, et al. Eur J Nucl Med Mol Imaging. 2023 Dec;51(1):183-195. doi: 10.1007/s00259-023-06383-1. Epub 2023 Sep 18. Eur J Nucl Med Mol Imaging. 2023. PMID: 37721581 Free PMC article. Clinical Trial.
107 results